{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:20:17Z","timestamp":1791591617134,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["D25019"],"award-info":[{"award-number":["D25019"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2023GXNSFBA026303"],"award-info":[{"award-number":["2023GXNSFBA026303"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019006","name":"State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources","doi-asserted-by":"publisher","award":["CMEMR2023-B17"],"award-info":[{"award-number":["CMEMR2023-B17"]}],"id":[{"id":"10.13039\/501100019006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014969","name":"Guilin Medical University","doi-asserted-by":"publisher","award":["GKLDDO-2023-P06"],"award-info":[{"award-number":["GKLDDO-2023-P06"]}],"id":[{"id":"10.13039\/501100014969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160657"],"award-info":[{"award-number":["82160657"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22467005"],"award-info":[{"award-number":["22467005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bmc.2025.118304","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T17:25:20Z","timestamp":1752600320000},"page":"118304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Discovery of novel thiourea benzenesulfonamides based 1,8-naphthalimide derivatives as carbonic anhydrase IX inhibitors that induce ferroptosis and inhibit triple-negative breast cancer metastasis"],"prefix":"10.1016","volume":"129","author":[{"given":"Jiajia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118304_bb0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.bmc.2025.118304_bb0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.bmc.2025.118304_bb0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2025.118304_bb0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s42255-019-0045-8","article-title":"Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy","volume":"1","author":"Ye","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.bmc.2025.118304_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2020.12.020","article-title":"Metabolic adaptation in hypoxia and cancer","volume":"502","author":"Paredes","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2025.118304_bb0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bmc.2025.118304_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2025.118304_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112923","article-title":"Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors","volume":"209","author":"Kumar","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0045","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1021\/acs.jmedchem.6b00616","article-title":"1,2-Benzisothiazole derivatives bearing 4-, 5-, or 6-alkyl\/arylcarboxamide moieties inhibit carbonic anhydrase isoform IX (CAIX) and cell proliferation under hypoxic conditions","volume":"59","author":"Coviello","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bmc.2025.118304_bb0055","doi-asserted-by":"crossref","first-page":"18556","DOI":"10.1002\/anie.202005362","article-title":"CAIXplatins: highly potent platinum(IV) prodrugs selective against carbonic anhydrase IX for the treatment of hypoxic tumors","volume":"59","author":"Cao","year":"2020","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmc.2025.118304_bb0060","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2025.118304_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114793","article-title":"Development of benzene and benzothiazole-sulfonamide analogues as selective inhibitors of the tumor-associated carbonic anhydrase IX","volume":"243","author":"Manzoor","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0070","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/acs.jmedchem.1c01906","article-title":"One-pot procedure for the synthesis of asymmetric substituted ureido benzene sulfonamides as effective inhibitors of carbonic anhydrase enzymes","volume":"65","author":"Vannozzi","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0075","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1021\/acs.jmedchem.8b00670","article-title":"4-substituted benzenesulfonamides incorporating bi\/tricyclic moieties act as potent and isoform-selective carbonic anhydrase II\/IX inhibitors","volume":"61","author":"Salerno","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0080","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/jm501798g","article-title":"Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site","volume":"58","author":"Tanpure","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115805","article-title":"Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors","volume":"261","author":"Ahmed","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115538","article-title":"Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer","volume":"258","author":"Eldehna","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0095","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.bmc.2025.118304_bb0100","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj0364","article-title":"Genome-wide synthetic lethal screen unveils novel CAIX-NFS1\/xCT axis as a targetable vulnerability in hypoxic solid tumors","volume":"7","author":"Chafe","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.bmc.2025.118304_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108440","article-title":"Role of carbonic anhydrases in ferroptosis-resistance","volume":"689","author":"Li","year":"2020","journal-title":"Arch Biochem Biophs"},{"key":"10.1016\/j.bmc.2025.118304_bb0110","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2025.118304_bb0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bmc.2025.118304_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904197","article-title":"Recent progress in ferroptosis inducers for cancer therapy","volume":"31","author":"Liang","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.bmc.2025.118304_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115937","article-title":"Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance","volume":"263","author":"Liang","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2023.134871","article-title":"A fluorescent prodrug to fight drug-resistant lung cancer cells via autophagy-driven ferroptosis","volume":"400","author":"Chen","year":"2024","journal-title":"Sensor Actuat B-Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105677","article-title":"Recent developments on 1,8-Naphthalimide moiety as potential target for anticancer agents","volume":"121","author":"Tandon","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112951","article-title":"Design, synthesis and antitumor evaluation of new 1, 8-naphthalimide derivatives targeting nuclear DNA","volume":"210","author":"Liang","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113300","article-title":"Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR\/CAIX dual inhibitors","volume":"216","author":"Zhang","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0150","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1021\/acs.jmedchem.0c02077","article-title":"Inhibition of carbonic anhydrase using SLC-149: support for a noncatalytic function of CAIX in breast cancer","volume":"64","author":"Mboge","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2017.03.023","article-title":"Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site","volume":"132","author":"Hou","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115805","article-title":"Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors","volume":"261","author":"Ahmed","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114008","article-title":"Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors","volume":"228","author":"Elimam","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105677","article-title":"Recent developments on 1,8-Naphthalimide moiety as potential target for anticancer agents","volume":"121","author":"Tandon","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0175","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1021\/acs.jmedchem.9b00945","article-title":"Metallacarborane sulfamides: unconventional, specific, and highly selective inhibitors of carbonic anhydrase IX","volume":"62","author":"Gr\u00fcner","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0180","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2025.118304_bb0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11307-015-0885-x","article-title":"Evaluation of CAIX and CAXII expression in breast cancer at varied O2 levels: CAIX is the superior surrogate imaging biomarker of tumor hypoxia","volume":"18","author":"Tafreshi","year":"2016","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.bmc.2025.118304_bb0190","doi-asserted-by":"crossref","first-page":"15911","DOI":"10.1074\/jbc.M300463200","article-title":"Cobalt inhibits the interaction between hypoxia-inducible factor alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor alpha","volume":"278","author":"Yuan","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0195","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0200","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.1021\/acs.jmedchem.4c00676","article-title":"Identification of 1,3,4-thiadiazolyl-containing thiazolidine-2,4-dione derivatives as novel PTP1B inhibitors with antidiabetic activity","volume":"67","author":"Li","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0205","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1021\/acs.jmedchem.4c00861","article-title":"Discovery of novel pyrimidine-based derivatives as Nav1.2 inhibitors with efficacy in mouse models of epilepsy","volume":"67","author":"He","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304081120","article-title":"A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis","volume":"120","author":"Kim","year":"2023","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2025.118304_bb0215","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","article-title":"Emerging mechanisms and targeted therapy of ferroptosis in cancer","volume":"29","author":"Wang","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.bmc.2025.118304_bb0220","doi-asserted-by":"crossref","unstructured":"Tomczyk MD, Walczak KZ. l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017. Eur J Med Chem 2018;159: 393\u2013422.","DOI":"10.1016\/j.ejmech.2018.09.055"},{"key":"10.1016\/j.bmc.2025.118304_bb0225","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/jm300529u","article-title":"Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts","volume":"55","author":"Pacchiano","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0230","doi-asserted-by":"crossref","first-page":"11351","DOI":"10.1021\/acs.jmedchem.3c00836","article-title":"Platinum(IV) complexes as inhibitors of STAT3 and regulators of the tumor microenvironment to control breast cancer","volume":"66","author":"Cai","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0235","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0240","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res"},{"issue":"19 Suppl","key":"10.1016\/j.bmc.2025.118304_bb0245","article-title":"Therapeutic targeting of cancer cells in the hypoxic microenvironment using an orally bioavailable small molecule inhibitor of carbonic anhydrase IX","volume":"74","author":"McDonald","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2025.118304_bb0250","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/acs.biochem.8b00337","article-title":"An emerging pathway of doxorubicin cardiotoxicity mediated through CYP2J2","volume":"57","author":"Arnold","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2025.118304_bb0255","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41698-018-0047-0","article-title":"Organotropism: new insights into molecular mechanisms of breast cancer metastasis","volume":"2","author":"Chen","year":"2018","journal-title":"Npj Precis Oncol"},{"key":"10.1016\/j.bmc.2025.118304_bb0260","doi-asserted-by":"crossref","first-page":"15374","DOI":"10.1021\/acs.jmedchem.2c01346","article-title":"Discovery of 3-Aminopyrazole derivatives as new potent and orally bioavailable AXL inhibitors","volume":"65","author":"Chan","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0265","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1021\/acs.jmedchem.2c02036","article-title":"Novel indole\u2013chalcone derivative-ligated platinum(IV) prodrugs attenuate cisplatin resistance in lung cancer through ROS\/ER stress and mitochondrial dysfunction","volume":"66","author":"Liu","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118304_bb0270","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.1021\/acs.jmedchem.3c00922","article-title":"Ligustrazine-derived chalcones-modified platinum(IV) complexes intervene in cisplatin resistance in pancreatic cancer through ferroptosis and apoptosis","volume":"66","author":"Wang","year":"2023","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:56:47Z","timestamp":1779771407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625002457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":54,"alternative-id":["S0968089625002457"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118304","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel thiourea benzenesulfonamides based 1,8-naphthalimide derivatives as carbonic anhydrase IX inhibitors that induce ferroptosis and inhibit triple-negative breast cancer metastasis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118304"}}